Skip to main content

Zinc and Fatty Acids in Depression

Neurochemical Research volume 35, pages 1376–1383 (2010)Cite this article

Abstract

Polyunsaturated Fatty acids (PUFAs) seem to be helpful in the therapy of depression. Zinc (Zn) may be one co-factor contributing to their antidepressive effect. Zn acts lipid protective and is a constituent of fatty acid metabolism enzymes. In animals, an antidepressive effect of Zn was already demonstrated. Therefore, if and how Zn and PUFAs correlate in depressive patients or in individuals from the general population was investigated. Blood samples were collected from 88 depressive in-patients and 88 volunteers from the general population matched for age-group and gender (each 32 men and 56 women, 21–70 years) for measurement of Zn (colorimetric) and of 12 fatty acids (FAs) (by capillary gas-chromatography). Severity of depression in patients was assessed by Beck Depression Inventory (BDI) and Hamilton Depression Rating Scale (HDRS). Zn concentration was independent of age, gender and body-mass-index and significantly correlated with the severity of depression measured by BDI (r = 0.26; P = 0.034) in depressive patients,. HDRS was inversely correlated with gammalinolenic acid concentration (r = −0.24; P = 0.029). Median serum Zn concentration in depressive patients did not differ from control individuals. Zn was correlated with myristic acid concentration (r = 0.22; P < 0.05) in controls from the general population; and a negative correlation between Zn and dihomogammalinolenic acid concentration (r = −0.26; P < 0.05) was found in depressive inpatients. FA composition in serum significantly differed between depressive and healthy persons: Depressive patients had higher stearic and arachidonic acid (AA) concentration. Relative to AA, their eicosapentaenoic and docosapentaenoic acid concentration were diminished compared to the general populations group. These results do not confirm the hypothesis of a general lack of Zn in depressive disorders, but Zn concentrations differed dependent on comorbid disorders and severity of depression. In depressive patients and control persons Zn concentration is associated with different FAs indicating diverging metabolic pathways.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Notes

  1. The following fatty acids were measured (in brackets the abbreviations used in the text) 14:0(MYR); 16:0(PA); 16:1(PAI); 18:0(STE); 18:1n-9(OL); 18:2 n-6(LA); 18:3n-6(GLA); 18:3n-3(ALA); 20:3n-(DGLA); 20:4n-6(AA); 20:5n-3(EPA); 22:6n-3 (DHA).

Abbreviations

AA:

Arachidonic acid 20:4n-6

ALA:

Alphalinolenic acid 18:3n-3

BDI:

Beck depression inventory

DGLA:

Dihommogammalinolenic acid (20:3n-6)

DHA:

Docosahexaenoic acid (22:6n-3)

EPA:

Eicosapentaenoic acid (20:5n-3)

FAs:

Fatty acids

GLA:

Gammalinolenic acid (18:3n-6)

HRSD:

Hamilton rating scale for depression

LA:

Linoleic acid (18:2n-6)

MYR:

Myristic acid (14:0)

OL:

Oleic acid (18:1n-9)

PAL:

Palmitic acid (16:0)

PAI:

Palmitoleic acid (16:1n-7)

PGE2:

Prostaglandin E2

PUFA:

Polyunsaturated fatty acid

STE:

Stearic acid (18:0)

Zn:

Zinc

References

  1. Lonergan PE, Martin DS, Horrobin DF et al (2004) Neuroprotective actions of eicosapentaenoic acid on lipopolysaccaride-induced dysfunction in rat hippocampus. J Neurochem 91:20–29

    Article  CAS  PubMed  Google Scholar 

  2. Song C, Leonard BE, Horrobin DF (2004) Dietary ethyl-eicosapentaenoic acid but not soybean oil reverses central interleukin-1-induced changes in behavior, corticosterone and immune response in rats. Stress 7:43–54

    Article  PubMed  Google Scholar 

  3. Severus WE, Ahrens B (2000) Omega-3 fatty acids in psychiatry. Nervenarzt 71:58–62. (Article in German)

    Google Scholar 

  4. Irmisch G, Schläfke D, Gierow W et al (2007) Fatty acids and sleep in depressed inpatients. Prostaglandins Leukot Essent Fat Acids 76:1–7

    Article  CAS  Google Scholar 

  5. Ross BM, Seguin J, Sieswerda LE (2007) Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid? Lipids Health Dis 6:21

    Article  PubMed  Google Scholar 

  6. Freeman MP, Hibbeln JR, Wisner KL et al (2006) Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 67:1954–1967

    Article  CAS  PubMed  Google Scholar 

  7. Calderon F, Kim HY (2004) Docosahexaenoic acid promotes neurite growth in hippocampal neurons. J Neurochem 90:979–988

    Article  CAS  PubMed  Google Scholar 

  8. Bourre JM (2006) Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 2: macronutrients. J Nutr Health Aging 10:386–399

    CAS  PubMed  Google Scholar 

  9. Mackenzie GG, Zago MP, Aimo L et al (2007) Zinc deficiency in neuronal biology. IUBMB Life 59:299–307

    Article  CAS  PubMed  Google Scholar 

  10. Nowak G, Szewczyk B (2002) Mechanisms contributing to antidepressant zinc actions. Pol J Pharmacol 54:587–592

    CAS  PubMed  Google Scholar 

  11. Marcellini F, Giuli C, Papa R et al (2006) Zinc status, psychological and nutritional assessment in old people recruited in five European countries: Zincage study. Biogerontology 7:339–345

    Article  CAS  PubMed  Google Scholar 

  12. Siwek MS, Wrobel A, Dudek D et al (2005) The role of zinc in the pathogenesis and treatment of affective disorders. [Article in Polish] Psychiatria polska 39:899–909

    Google Scholar 

  13. Levenson CW (2006) Zinc: the new antidepressant? Nutr Rev 64:39–42

    Article  PubMed  Google Scholar 

  14. Maes M, Mihaylova I, Leunis JC (2005) In chronic fatigue syndrome, the decreased levels of omega-3 poly-unsaturated fatty acids are related to lowered serum zinc and defects in T cell activation. Neuro Endocrinol Lett 26:745–751

    CAS  PubMed  Google Scholar 

  15. Yousef MI, El-Hendy HA, El-Demerdash FM et al (2002) Dietary zinc deficiency induced-changes in the activity of enzymes and the levels of free radicals, lipids and protein electrophoretic behavior in growing rats. Toxicology 175:223–234

    Article  CAS  PubMed  Google Scholar 

  16. Irmisch G, Schläfke D, Richter J (2006) Relationships between fatty acids and psychophysiological parameters in depressive inpatients under experimentally induced stress. Prostaglandins Leukot Essent Fat Acids 74:149–156

    Article  CAS  Google Scholar 

  17. Beck AT, Ward CH, Mendelson M et al (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571

    CAS  PubMed  Google Scholar 

  18. Hamilton MA (1960) A rating scale for depression. J Clin Psychiatry 23:56–62

    CAS  Google Scholar 

  19. Maes M, Van-de-Vyvere J, Vandoolaeghe E et al (1996) Alterations in iron metabolism and the erythron in major depression: further evidence for a chronic inflammatory process. J Affect Disord 40:23–33

    Article  CAS  PubMed  Google Scholar 

  20. Maes M, D’Haese PC, Scharpe S et al (1994) Hypozincemia in depression. J Affect Disord 31:135–140

    Article  CAS  PubMed  Google Scholar 

  21. Larsen MH, Mikkelsen JD, Hay-Schmidt A, Sandi C (2010) Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment. J Psychiatr Res, Feb 19 (Epub ahead of print)

  22. Sowa-Kućma M, Legutko B, Szewczyk B, Novak K, Znojek P, Poleszak E, Papp M, Pilc A, Nowak G (2008) Antidepressant-like activity of zinc: further behavioral and molecular evidence. J Neural Transm 115:1621–1628

    Article  PubMed  Google Scholar 

  23. Maes M, Vandoolaeghe E, Neels H et al (1997) Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness. Biol Psychiatry 42:349–358

    Article  CAS  PubMed  Google Scholar 

  24. Narang RL, Gupta KR, Narang AP, Singh R (1991) Levels of copper and zinc in depression. Indian J Physiol Pharmacol 35:272–274

    CAS  PubMed  Google Scholar 

  25. Yazici KM, Akinci A, Sutcu A et al (2003) Bone mineral density in premenopausal women with major depressive disorder. Psychiatry Res 117:271–275

    Article  PubMed  Google Scholar 

  26. Battaglino R, Fu J, Späte U et al (2004) Serotonin regulates osteoclast differentiation through its transporter. J Bone Miner Res 19:1420–1431

    Article  CAS  PubMed  Google Scholar 

  27. Mollard RC, Weiler HA (2006) Dietary arachidonic acid and docosahexaenoic acid elevate femur calcium and reduce zinc content in piglets. Pediatr Res 60:418–422

    Article  CAS  PubMed  Google Scholar 

  28. Eder K, Kirchgessner M (1994) The effect of zinc deficiency on heart and brain lipids in rats force-fed with coconut oil or fish oil diets. Zeitschrift für Ernährungswissenschaft 33:136–145. (Article in German)

    Google Scholar 

  29. Tom Dieck H, Döring F, Fuchs D, Roth HP, Daniel H (2005) Transcriptome and proteome analysis identifies the pathways that increase hepatic lipid accumulation in zinc-deficient rats. J Nutr 135:199–205

    CAS  PubMed  Google Scholar 

  30. Eder K, Kirchgessner M (1996) Zinc deficiency and the desaturation of linoleic acid in rats force-fed fat-free diets. Biol Trace Elem Res 54:173–183

    Article  CAS  PubMed  Google Scholar 

  31. Izumi Y, Auberson YP, Zorumski CF (2006) Zinc modulates bidirectional hippocampal plasticity by effects on NMDA receptors. J Neurosci 26:7181–7188

    Article  CAS  PubMed  Google Scholar 

  32. Hirzel K, Müller U, Latal AT et al (2006) Hyperekplexia phenotype of glycine receptor alpha1 subunit mutant mice identifies Zn (2+) as an essential endogenous modulator of glycinergic neurotransmission. Neuron 52:679–690

    Article  CAS  PubMed  Google Scholar 

  33. Chen BW, Wang HH, Liu JX, Liu XG (1999) Zinc sulphate solution enema decreases inflammation in experimental colitis in rats. J Gastroenterol Hepatol 14:1088–1092

    Article  CAS  PubMed  Google Scholar 

  34. Siwek M, Dudek D, Paul IA, Sowa-Kućma M, Zieba A, Popik P, Pilc A, Nowak G (2009) Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study. J Affect Disord 118:187–195

    Article  CAS  PubMed  Google Scholar 

  35. Müller N (2010) COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence. Curr Opin Investig Drugs 11:31–42

    PubMed  Google Scholar 

  36. Conklin SM, Runyan CA, Leonard S, Reddy RD, Muldoon MF, Yao JK (2010) Age-related changes of n-3 and n-6 polyunsaturated fatty acids in the anterior cingulate cortex of individuals with major depressive disorder. Prostaglandins Leukot Essent Fat Acids 82:111–119

    Article  CAS  Google Scholar 

  37. Yager S, Forlenza MJ, Miller GE (2010) Depression and oxidative damage to lipids. Psychoneuroendocrinology. Apr 21 (Epub ahead of print)

  38. Lehto SM, Ruusunen A, Niskanen L, Tolmunen T, Voutilainen S, Viinamäki H, Kaplan GA, Kauhanen J (2010) Elevated depressive symptoms and compositional changes in LDL particles in middle-aged men. Eur J Epidemiol. Apr 23 (Epub ahead of print)

  39. Khan FM, Kulaksizoglu B, Cilingiroglu M (2010) Depression and coronary heart disease. Curr Atheroscler Rep 12:105–109

    Article  PubMed  Google Scholar 

  40. Mozaffarian D, Micha R, Wallace S (2010) Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 23:e1000252

    Google Scholar 

  41. High KP, Sinclair J, Easter LH, Case D, Chilton FH (2003) Advanced age, but not anergy, is associated with altered serum polyunsaturated fatty acid levels. J Nutr Health Aging 7:378–384

    CAS  PubMed  Google Scholar 

  42. Yanagisawa N, Shimada K, Miyazaki T, Kume A, Kitamura Y, Ichikawa R, Ohmura H, Kiyanagi T, Hiki M, Fukao K, Sumiyoshi K, Hirose K, Matsumori R, Takizawa H, Fujii K, Mokuno H, Inoue N, Daida H (2010) Polyunsaturated fatty acid levels of serum and red blood cells in apparently healthy Japanese subjects living in an urban area. J Atheroscler Thromb 17:285–294

    PubMed  Google Scholar 

  43. Micallef M, Munro I, Phang M, Garg M (2009) Plasma n-3 polyunsaturated fatty acids are negatively associated with obesity. Br J Nutr 102:1370–1374

    Article  CAS  PubMed  Google Scholar 

  44. McNamara RK, Able J, Jandacek R, Rider T, Tso P (2009) Gender differences in rat erythrocyte and brain docosahexaenoic acid composition: role of ovarian hormones and dietary omega-3 fatty acid composition. Psychoneuroendocrinology 34:532–539

    Article  CAS  PubMed  Google Scholar 

  45. Laidlaw M, Holub BJ (2003) Effects of supplementation with fish oil-derived n-3 fatty acids and gamma-linolenic acid on circulating plasma lipids and fatty acid profiles in women. Am J Clin Nutr 77:37–42

    CAS  PubMed  Google Scholar 

  46. Ghezzi S, Risé P, Ceruti S et al (2007) Effects of cigarette smoke on cell viability, linoleic acid metabolism and cholesterol synthesis, in THP-1 cells. Lipids 42:629–636

    Google Scholar 

  47. Szewczyk B, Poleszak E, Sowa-Kućma M, Siwek M, Dudek D, Ryszewska-Pokraśniewicz B, Radziwoń-Zaleska M, Opoka W, Czekaj J, Pilc A, Nowak G (2008) Antidepressant activity of zinc and magnesium in view of the current hypotheses of antidepressant action. Pharmacol Rep 60:588–599

    Google Scholar 

Download references

Acknowledgments

The research project was supported by the German Research Foundation (DFG Er 225/2-1). There exists no conflict of interest.

Author information

Affiliations

  1. Psychiatric University Hospital, Universität Rostock, Medizinische Fakultät, Neurochemisches Labor der Klinik für Psychiatrie and Psychotherapie, Gehlsheimer Str.20, 18147, Rostock, Germany

    Gisela Irmisch

  2. Universität Rostock, Medizinische Fakultät, Klinik für Forensische Psychiatrie, Gehlsheimer Str.20, 18147, Rostock, Germany

    Detlef Schlaefke

  3. Norway Centre for Child and Adolescent Mental Health Eastern and Southern Norway, 0405, Oslo, Norway

    Joerg Richter

Authors
  1. Gisela Irmisch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Detlef Schlaefke
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joerg Richter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gisela Irmisch.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Irmisch, G., Schlaefke, D. & Richter, J. Zinc and Fatty Acids in Depression. Neurochem Res 35, 1376–1383 (2010). https://doi.org/10.1007/s11064-010-0194-3

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11064-010-0194-3

Keywords

  • Zinc
  • Fatty acids
  • Depression